Report Detail
(Post-pandemic Era)-Global Biosimilar Testing and Development Services Market Segment Research Report 2022
- RnM4087254 |
- 04 August, 2022 |
- Global |
- 108 Pages |
- XYZResearch |
- Pharma & Healthcare
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Biosimilar Testing and Development Services Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Biosimilar Testing and Development Services industry at home and abroad, estimate the overall market scale of the Biosimilar Testing and Development Services industry and the market share of major countries, Biosimilar Testing and Development Services industry, and study and judge the downstream market demand of Biosimilar Testing and Development Services through systematic research, Analyze the competition pattern of Biosimilar Testing and Development Services, so as to help solve the pain points of various stakeholders in Biosimilar Testing and Development Services industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Biosimilar Testing and Development Services Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Biosimilar Testing and Development Services Market?
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Major Type of Biosimilar Testing and Development Services Covered in XYZResearch report:
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Application Segments Covered in XYZResearch Market
PK assay
Tiered Immunogenicity testing
NAb assays
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Biosimilar Testing and Development Services Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Biosimilar Testing and Development Services Market by Value
- 2.2.1 Global Biosimilar Testing and Development Services Revenue by Type
- 2.2.2 Global Biosimilar Testing and Development Services Market by Value (%)
- 2.3 Global Biosimilar Testing and Development Services Market by Production
- 2.3.1 Global Biosimilar Testing and Development Services Production by Type
- 2.3.2 Global Biosimilar Testing and Development Services Market by Production (%)
3. The Major Driver of Biosimilar Testing and Development Services Industry
- 3.1 Historical & Forecast Global Biosimilar Testing and Development Services Demand
- 3.2 Largest Application for Biosimilar Testing and Development Services (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Biosimilar Testing and Development Services Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Biosimilar Testing and Development Services Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Biosimilar Testing and Development Services Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Biosimilar Testing and Development Services Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Biosimilar Testing and Development Services Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Biosimilar Testing and Development Services Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Biosimilar Testing and Development Services Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Biosimilar Testing and Development Services Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Biosimilar Testing and Development Services Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Biosimilar Testing and Development Services Average Price Trend
- 12.1 Market Price for Each Type of Biosimilar Testing and Development Services in US (2018-2022)
- 12.2 Market Price for Each Type of Biosimilar Testing and Development Services in Europe (2018-2022)
- 12.3 Market Price for Each Type of Biosimilar Testing and Development Services in China (2018-2022)
- 12.4 Market Price for Each Type of Biosimilar Testing and Development Services in Japan (2018-2022)
- 12.5 Market Price for Each Type of Biosimilar Testing and Development Services in India (2018-2022)
- 12.6 Market Price for Each Type of Biosimilar Testing and Development Services in Korea (2018-2022)
- 12.7 Market Price for Each Type of Biosimilar Testing and Development Services in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Biosimilar Testing and Development Services Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Biosimilar Testing and Development Services
14. Biosimilar Testing and Development Services Competitive Landscape
- 14.1 Eurofins Scientific
- 14.1.1 Eurofins Scientific Company Profiles
- 14.1.2 Eurofins Scientific Product Introduction
- 14.1.3 Eurofins Scientific Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 SGS
- 14.2.1 SGS Company Profiles
- 14.2.2 SGS Product Introduction
- 14.2.3 SGS Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 Charles River Laboratories
- 14.3.1 Charles River Laboratories Company Profiles
- 14.3.2 Charles River Laboratories Product Introduction
- 14.3.3 Charles River Laboratories Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Pharmaceutical Product Development
- 14.4.1 Pharmaceutical Product Development Company Profiles
- 14.4.2 Pharmaceutical Product Development Product Introduction
- 14.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Exova
- 14.5.1 Exova Company Profiles
- 14.5.2 Exova Product Introduction
- 14.5.3 Exova Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Source BioScience
- 14.6.1 Source BioScience Company Profiles
- 14.6.2 Source BioScience Product Introduction
- 14.6.3 Source BioScience Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 Intertek Group
- 14.7.1 Intertek Group Company Profiles
- 14.7.2 Intertek Group Product Introduction
- 14.7.3 Intertek Group Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Medistri
- 14.8.1 Medistri Company Profiles
- 14.8.2 Medistri Product Introduction
- 14.8.3 Medistri Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Pace Analytical Services
- 14.9.1 Pace Analytical Services Company Profiles
- 14.9.2 Pace Analytical Services Product Introduction
- 14.9.3 Pace Analytical Services Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 Sigma-Aldrich
- 14.10.1 Sigma-Aldrich Company Profiles
- 14.10.2 Sigma-Aldrich Product Introduction
- 14.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Biosimilar Testing And Development Services. Industry analysis & Market Report on Biosimilar Testing And Development Services is a syndicated market report, published as (Post-pandemic Era)-Global Biosimilar Testing and Development Services Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Biosimilar Testing And Development Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
